State Street Corp Royalty Pharma PLC Transaction History
State Street Corp
- $2.25 Trillion
- Q2 2024
A detailed history of State Street Corp transactions in Royalty Pharma PLC stock. As of the latest transaction made, State Street Corp holds 9,486,811 shares of RPRX stock, worth $268 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
9,486,811
Previous 9,100,148
4.25%
Holding current value
$268 Million
Previous $276 Million
9.48%
% of portfolio
0.01%
Previous 0.01%
Shares
17 transactions
Others Institutions Holding RPRX
# of Institutions
397Shares Held
291MCall Options Held
305KPut Options Held
138K-
Morgan Stanley New York, NY44.1MShares$1.25 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA38MShares$1.07 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$649 Million0.01% of portfolio
-
Baillie Gifford & CO16.4MShares$461 Million0.34% of portfolio
-
Viking Global Investors LP12MShares$338 Million1.26% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $12.3B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...